Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Treatments for melanin disorders exist, but more effective options needed.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Minoxidil in breast milk may harm nursing infants.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Transplant patients often get skin problems, with treatments varying by condition.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.